For much of the history of in-vitro fertilisation (IVF), technological advances have focused overwhelmingly on the egg and the embryo. Advances in ovarian stimulation protocols, time-lapse embryo imaging, genetic testing and cryopreservation have dramatically improved...
Why Amazing Medical Technologies Fail (And How to Ensure Yours Doesn’t)
Have you considered what it means to have an FDA-approved, life-changing, medical product? It’s nothing short of amazing! However, let me add on to that question, have you considered what it means to have an FDA-approved, life changing, medical product WITHOUT a...
The Microbiome, as a Performance Regulator: Gut Integrity Under Physiological Load
In high-performance populations — elite athletes, tactical operators, founders, executives under sustained cognitive load — resilience is typically framed in terms of cardiovascular output, muscular strength, mitochondrial density or hormonal optimisation. Yet one of...
Why Health Platforms Built for Millennials Will Fail Gen Alpha
The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...
A Decentralized Advantage: Outpatient Theranostics is the Clinical Standard
While oncology has historically relied on a "Hospital-as-Hub" model, the specific logistical demands of radiopharmaceutical therapy (RPT) are revealing its limitations. The decentralized outpatient model is emerging as a significant industry trend, demonstrating that...
The Convergence Era: How Data and AI are Reshaping Life Sciences
For decades, innovation in life sciences followed a familiar path: lab discovery, clinical testing, regulatory approval, market release. It was linear. Predictable. Slow. What’s happening now feels different. The most significant shift isn’t a single breakthrough...
Fertility Decisions and AI: Clarity Without False Certainty
As a researcher studying how people interact with large language models (LLMs), and as a clinician trained at the master’s level in clinical psychology, I keep seeing the same pattern in fertility and reproductive contexts. People rarely turn to AI only for...
AI-Enabled Pathology: De-risking Oncology Drug Development
Today, oncology drug development continues to experience the highest attrition rates across therapeutic areas[1]. Despite major advances in molecular profiling and biomarker-driven strategies, a significant proportion of oncology clinical trials still fail, often due...
Why Sugar May Matter More Than We Thought
A New Energy-Centered Model of Metabolic Disease For decades, sugar has been framed as a problem of excess. Too many calories. Too many insulin spikes. Too much sweetness in the modern diet. That framing has shaped public health guidance, food reformulation, and...
Cera and Promptly Health Partner to Bridge the ‘Evidence Gap’
Cera, Europe’s largest digital-first home healthcare provider, has announced a global real-world evidence (RWE) partnership with Promptly Health, focused on the over-65s, to accelerate drug development and enable precision medicine. The partnership integrates Cera’s...
RCM Efficiency: Solving Insurance Denials & Margin Pressure
Insurance Denials and Revenue Cycle Inefficiencies Are Becoming a Primary Driver of Hospital Financial Strain U.S. hospitals are entering the next fiscal cycle under sustained financial pressure, and insurance denials have emerged as one of the most consequential, yet...
Chronic Pain and Neuroplastic Pain: Rethinking How Pain is Created
Chronic pain affects hundreds of millions of people worldwide and remains one of the most challenging problems in modern medicine. For decades, pain has largely been understood as a direct signal of tissue damage or disease. However, advances in pain science are...
Neuroscience of Trauma, Stress & Alcohol: Integrated Treatment
Alcohol problems are often framed as a failure of willpower or “poor lifestyle choices”. Yet clinical neuroscience has made that narrative increasingly untenable. Problematic alcohol use is often a learned response to stress, a learned neurobiological adaptation,...
AI in Life Science Marketing: What’s Actually Working Beyond the Hype
Life science marketing teams are drowning in complexity. Regulatory compliance demands are tightening, scientific accuracy is non-negotiable, and sales cycles stretch 18-24 months or longer. Meanwhile, CMOs face relentless pressure to prove ROI faster while managing...
The Blind Men and the Elephant: A Parable for Modern Pain Management
Most of us have heard the ancient Indian and Buddhist parable “the blind men and the elephant.” Regardless of source, the parable usually contains these elements: A ruler assembles several blind men and brings an elephant before them. One feels the head and says the...
Innovate UK Awards Over £300k SMART Grant
Funding supports the co-design and roll-out of MEMORI, a Class IIb CE-certified SaMD platform, tailored to local clinical teams and systems MEMORI analyses multimodal clinical data in real-time to accurately predict the risk of hospital-acquired infections, alerting...
Re:Cognition Health & Cera to Expand Access to Alzheimer’s Trials
Re:Cognition Health, a global leader in brain and memory health research, and Cera, Europe’s largest digital-first home healthcare provider, today announce a new collaboration designed to expand access to Alzheimer’s and neurodegenerative clinical trials and support...
Biomanufacturing is the Next Industrial Revolution
Across the life sciences sector, a profound shift is underway. Biomanufacturing is poised to become a foundational pillar of how we will make things in the 21st century. Advances in bioreactor design, synthetic biology, and sustainable bioprocessing are enabling...






